Resources for You (Biologics)
Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, …
Category: US National Health Agency Sources
Center for Biologics Evaluation and Research Patient Engagement Program
Patient input is a critical part of CBER’s understanding of diseases and conditions. Engaging with patients and listening to their perspectives on t…
Update: COVID-19 Vaccine Booster Composition
FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) held a virtual meeting on June 28, 2022, to publicly discuss whether a ch…
Patients assemble for very special story hour
Patients at the Spinal Cord Injury and Disorders Center at Jefferson Barracks VA assembled recently for a very special story hour.
FDA Roundup: March 21, 2025
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Recently Issued Guidance Documents
This page lists Recently Issued CBER and Cross-Center Guidance Documents.
Antimicrobial Resistance
Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, com…